Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Stacie Dusetzina Profile picture
Stacie Dusetzina
@DusetzinaS
Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
Aug 29, 2023 • 4 tweets • 2 min read
Are you feeling down because the drug that you take isn't on the list that @CMSGov just released for price negotiations in #PartD? FEAR NOT. You also get to benfit from negotiation. Let me explain how. 1/4 Medicare negotiations will save the program a ton of money. That money is actually being used, in part, to pay to expand the #PartD benefit to make it better for enrollees. The benfit will be redesigned in 2025. What does that mean for you or your loved ones on #PartD? 2/4
Nov 14, 2022 • 10 tweets • 9 min read
💊💊TWEETORIAL ALERT!! 💊💊
Because last week was a busy week for #insulin tweets, @KhrystaBaig and I have saved this Tweetorial for our new @JAMA_current paper for a...um...less busy time. AHEM, remember? 👇 Follow along, will you? 1/10 Image A little background before we dive into GIFs. While #insulin isn't free, it is only $35 on some plans in #PartD as part of the @CMSinnovates #SeniorSavings Model. But who saves money under this model? 2/10
jamanetwork.com/journals/jama/…
May 4, 2022 • 8 tweets • 8 min read
💊💊 New Tweetorial Alert 💊💊
Please take a break from your #doomscrolling and read this thread. If you have an even longer break read the paper @NEJM: nejm.org/doi/full/10.10… 1/7 This paper is about #PartD & cancer. It is also about #pharmacoequity (shoutout @UREssien). Not the way we typically think about equity, though. This is about how screwed you are if you need cancer treatment and your treatment happens to be covered by #PartD and not #PartB. 2/7
Nov 10, 2021 • 11 tweets • 12 min read
💊💊TWEETORIAL ALERT💊💊
New work out this evening in @NEJM @NEJMPerspec on the plan to redesign #Medicare #PartD and how much savings there might be for people enrolled in the program! This has been a moving target (I'm looking at you #BuildBackBetter)! I've got you covered! 1/7 The article is here for your reading pleasure:
nejm.org/doi/full/10.10…
Oct 20, 2021 • 8 tweets • 6 min read
💊💊💊NEW TWEETORIAL 💊💊💊
This is about #PartD and #AuthorizedGenerics and how some generics aren't a very good deal for health plans, even if they provide savings to patients. With @profmikecarrier @NancyKeatingMD @AmeetSarpatwari. 1/7
jamanetwork.com/journals/jamai… You might remember headlines like this one that were telling us about companies coming out with generic versions of their $$$$ brand-name drugs. We saw this for #insulin #hepatitisC and #epipen over the past few years. 2/7
nytimes.com/2019/03/04/hea…
Jul 27, 2020 • 12 tweets • 3 min read
Last week my mom was diagnosed with metastatic (stage IV) breast cancer. As someone who has worked in the pharmaceutical industry, studies cancer drug prices, and is trained as a health services researcher, I have some thoughts to share about our current system. 1/10 First, #Cancer sucks. Metastatic cancer is something I hope you never have to say to or hear from someone that you love. When it is you, or your loved one, you desperately want more time. You want good quality of life, and you need for them to live. 2/10
Jul 1, 2019 • 11 tweets • 6 min read
We have a new study out today in @Health_Affairs on #PartD. Bear with me because the findings are a little crazy. You can find the paper here:
healthaffairs.org/doi/full/10.13… 1/10 Our big finding: If you need a lot of drugs or some very expensive drugs you would save more money out-of-pocket by using brands instead of generics. 2/10